Our Story

It all started with a pretty simple question: If we know the best way to treat the diseases that hurt us the most, then why doesn’t everybody get the best care?  The answer, though, turned out to be a lot more complicated.  Misaligned incentives, poor coordination, defensive medicine, and even some of our own attitudes are keeping us in pain.  Risalto set out to change all of that.

Launched with the backing of Oxeon Partners in 2016, Risalto aimed to bring the most effective care to every patient.  In order to accomplish this, it was clear that we couldn't just create another digital health solution, we had to rethink everything from how a member becomes a patient, to that patient's relationship with their provider universe, to the hard and soft incentives that motivate those providers.  In the process, we brought together leading experts in musculoskeletal care, health economics and analytics, care management, and health insurance to lead our founding team.  With their insights, we are learning how to identify the best providers, incentivize and support more providers in being the best, and create a connected, concierge led patient journey that helps patients get better, faster.  



 
lightbulb offset.png
 

Visit our blog to learn more about news and events.


 

Our Team

 Dan founded Risalto in 2016 with the mission of helping more patients get the highest standard of care. Prior to Risalto, Dan was an engagement manager at McKinsey & Company and then the provider domain manager for McKinsey Healthcare Analytics.  Dan holds an MD from Columbia University's College of Physicians and Surgeons, and a BA from Columbia University.

Dan founded Risalto in 2016 with the mission of helping more patients get the highest standard of care. Prior to Risalto, Dan was an engagement manager at McKinsey & Company and then the provider domain manager for McKinsey Healthcare Analytics.

Dan holds an MD from Columbia University's College of Physicians and Surgeons, and a BA from Columbia University.

Dan Pizzarello, MD
Founder & CEO

 
 Rosemary joins Risalto as a Registered Nurse with over 20 years’ experience in health care operations - telemedicine, remote patient monitoring, urgent and chronic care management. Previously, Rosemary led field-based and call center operations for an intellectually / developmentally disabled population program.  She has also held roles as the Chief Nursing Officer and SVP at AMC Health, a telehealth company, and with Horizon BCBS of NJ, developing, launching and operating care coordination programs for Chronic Kidney Disease and rare diseases.  Rosemary received her nursing training from the Holy Name Hospital School of Nursing in Teaneck, NJ. She Holds a B.S. in Healthcare Administration from St. Peter’s College and an MPA from Fairleigh Dickinson University.

Rosemary joins Risalto as a Registered Nurse with over 20 years’ experience in health care operations - telemedicine, remote patient monitoring, urgent and chronic care management. Previously, Rosemary led field-based and call center operations for an intellectually / developmentally disabled population program.  She has also held roles as the Chief Nursing Officer and SVP at AMC Health, a telehealth company, and with Horizon BCBS of NJ, developing, launching and operating care coordination programs for Chronic Kidney Disease and rare diseases.

Rosemary received her nursing training from the Holy Name Hospital School of Nursing in Teaneck, NJ. She Holds a B.S. in Healthcare Administration from St. Peter’s College and an MPA from Fairleigh Dickinson University.

Rosemary Glavan, RN
Head of Care Management

 
 Gerry is a practicing senior physical therapist at NYU Langone Orthopedic Center.   Gerry holds a BS and MS from Nazareth College. He a Diplomate of Mechanical Diagnosis and Therapy as well as a Fellow of the American Academy of Orthopedic Manual Physical Therapists.

Gerry is a practicing senior physical therapist at NYU Langone Orthopedic Center. 

Gerry holds a BS and MS from Nazareth College. He a Diplomate of Mechanical Diagnosis and Therapy as well as a Fellow of the American Academy of Orthopedic Manual Physical Therapists.

Gerry Gordon, PT
Physical Therapy Advisor

 
 Dave joined Risalto after years of orthopaedic clinical practice and leadership. He is Chair of Orthopaedics at the Geisel School of Medicine at Dartmouth. Previously, he was the Medical Director of the Orthopaedic Clinical Program at Intermountain Healthcare. Dave also founded Zion Orthopaedics and Sports Medicine in Southern Utah.  Dave received his MD, summa cum laude and AOA, from the Georgetown School of Medicine and his MBA, magna cum laude, from the Raymond J. Harbert School of Business at Auburn.

Dave joined Risalto after years of orthopaedic clinical practice and leadership. He is Chair of Orthopaedics at the Geisel School of Medicine at Dartmouth. Previously, he was the Medical Director of the Orthopaedic Clinical Program at Intermountain Healthcare. Dave also founded Zion Orthopaedics and Sports Medicine in Southern Utah.

Dave received his MD, summa cum laude and AOA, from the Georgetown School of Medicine and his MBA, magna cum laude, from the Raymond J. Harbert School of Business at Auburn.

David Jevsevar, MD
Executive Medical Director

 
 Schuyler came to Risalto from KATE, where he helped transform medical claims data into a consumer-facing medical history app. Before that, Schuyler helped Oscar Health revamp their claims processing system, improving on-time performance from 80% to 98% in two quarters. Previously, he interned at UBS Wealth Management and EGA, an emerging markets asset manager.

Schuyler came to Risalto from KATE, where he helped transform medical claims data into a consumer-facing medical history app. Before that, Schuyler helped Oscar Health revamp their claims processing system, improving on-time performance from 80% to 98% in two quarters. Previously, he interned at UBS Wealth Management and EGA, an emerging markets asset manager.

Schuyler Wolf
Product Manager - Data

 
 Marcin joined Risalto while working at Eight where he headed the Data Engineering practice. Prior to Risalto and Eight, Marcin held various Data Science and Engineering roles at Komodo Health, Hooklogic and Yahoo.  Marcin holds an MS in Statistics and a BS from Stanford University.

Marcin joined Risalto while working at Eight where he headed the Data Engineering practice. Prior to Risalto and Eight, Marcin held various Data Science and Engineering roles at Komodo Health, Hooklogic and Yahoo.

Marcin holds an MS in Statistics and a BS from Stanford University.

Marcin Mejran

Data Scientist

 
 Allison joined Risalto out of the Oxeon Venture Studio, where she worked closely with Risalto during the company's first year. Prior to Oxeon, Allison held positions with naviHealth, Providence Equity Partners in the NYC-based Portfolio Operations Group, and McKinsey & Company.  Allison holds an MBA from Harvard Business School, and a BS, summa cum laude, from Columbia University.   

Allison joined Risalto out of the Oxeon Venture Studio, where she worked closely with Risalto during the company's first year. Prior to Oxeon, Allison held positions with naviHealth, Providence Equity Partners in the NYC-based Portfolio Operations Group, and McKinsey & Company.

Allison holds an MBA from Harvard Business School, and a BS, summa cum laude, from Columbia University.

 

Allison Schoeneck
Head of Clinical Product

 
 Dr. Farah Hameed currently serves as a practicing physician and an Assistant Professor at the Columbia College of Physicians and Surgeons in the Department of Rehabilitation and Regenerative Medicine.   Farah received her MD from the University of Texas Medical Branch and her undergraduate degree, with honors, from the University of Texas at Austin.  She completed her residency at Harvard Medical School/Spaulding Rehabilitation Hospital and her fellowship in Spine and Sports Medicine at Northwest University through the Rehabilitation Institute of Chicago, where she won a Baskin Award for excellence in research. She is Board certified in both Physical Medicine and Rehabilitation and Sports Medicine.

Dr. Farah Hameed currently serves as a practicing physician and an Assistant Professor at the Columbia College of Physicians and Surgeons in the Department of Rehabilitation and Regenerative Medicine. 

Farah received her MD from the University of Texas Medical Branch and her undergraduate degree, with honors, from the University of Texas at Austin.  She completed her residency at Harvard Medical School/Spaulding Rehabilitation Hospital and her fellowship in Spine and Sports Medicine at Northwest University through the Rehabilitation Institute of Chicago, where she won a Baskin Award for excellence in research. She is Board certified in both Physical Medicine and Rehabilitation and Sports Medicine.

Farah Hameed, MD
Medical Advisor

 
Risalto-Bio-Pic_250x250px_Circle_Zoe-Weil.png

Zoë Weil

Machine Learning Engineer

 

 
 David Whelan runs Oxeon Ventures, the venture start-up studio and investment business at Oxeon Holdings, Risalto's seed funder.  David was previously a General Partner of Accretive LLC, during which time he served as director on the portfolio company boards of Arise Virtual Solutions and Insureon. Before that, David held the roles of  Chief Executive Officer of the Cloverleaf Group and Vice President of Corporate Development with the Virgin Group.  David has a Bachelor of Laws (Honours) and Bachelor of Commerce from Bond University in Queensland, Australia

David Whelan runs Oxeon Ventures, the venture start-up studio and investment business at Oxeon Holdings, Risalto's seed funder.  David was previously a General Partner of Accretive LLC, during which time he served as director on the portfolio company boards of Arise Virtual Solutions and Insureon. Before that, David held the roles of  Chief Executive Officer of the Cloverleaf Group and Vice President of Corporate Development with the Virgin Group.

David has a Bachelor of Laws (Honours) and Bachelor of Commerce from Bond University in Queensland, Australia

David Whelan
Board Member

 Vince joined the board of Risalto and advises the company on strategic, product, and business development matters. Vince is currently President and CEO of IPG, the leading medical device management company. Vince is focused on driving IPG’s value for clients by advancing IPG's capabilities and solutions.  Before joining IPG, Vince was President and CEO of Triad, a leading musculoskeletal care management company. Under Vince’s leadership, Triad became a leader in its market, experienced significant growth and profitability, and in 2013, the company was acquired by MedSolutions (now EviCore).  Post-acquisition, Vince continued as CEO to ensure a successful integration and its continued strong growth. Previous experience includes leading Strategy and Business Development for Blue Shield of California, where he developed strategies to increase the company’s market position and competitiveness. Earlier, he led Corporate Development for Magellan Health Services where he developed and executed on a successful diversification strategy by expanding into Radiology and Pharmacy, which is still the core of the company’s growth and profitability today. Vince also held leading positions at United Health Group, Cigna, JP Morgan and GE Capital.

Vince joined the board of Risalto and advises the company on strategic, product, and business development matters. Vince is currently President and CEO of IPG, the leading medical device management company. Vince is focused on driving IPG’s value for clients by advancing IPG's capabilities and solutions.  Before joining IPG, Vince was President and CEO of Triad, a leading musculoskeletal care management company. Under Vince’s leadership, Triad became a leader in its market, experienced significant growth and profitability, and in 2013, the company was acquired by MedSolutions (now EviCore).  Post-acquisition, Vince continued as CEO to ensure a successful integration and its continued strong growth. Previous experience includes leading Strategy and Business Development for Blue Shield of California, where he developed strategies to increase the company’s market position and competitiveness. Earlier, he led Corporate Development for Magellan Health Services where he developed and executed on a successful diversification strategy by expanding into Radiology and Pharmacy, which is still the core of the company’s growth and profitability today. Vince also held leading positions at United Health Group, Cigna, JP Morgan and GE Capital.

Vince Coppola
Board Member

 Alan is a physician executive with a long and rich background in health strategy, employer sponsored health care, managed care, and medical policy. Alan is currently Chief Medical Officer of Medica and Chairman of the Medical Advisory Board of Accolade. Previously, Alan co-founded Accolade and served as their Chief Medical Officer for nine years, lead the Clinical Practice at Towers Perrin, and served as Chief Medical Officer for the National Accounts division of WellPoint.

Alan is a physician executive with a long and rich background in health strategy, employer sponsored health care, managed care, and medical policy. Alan is currently Chief Medical Officer of Medica and Chairman of the Medical Advisory Board of Accolade. Previously, Alan co-founded Accolade and served as their Chief Medical Officer for nine years, lead the Clinical Practice at Towers Perrin, and served as Chief Medical Officer for the National Accounts division of WellPoint.

Alan Spiro, MD
Advisory Board

 

Our Partners

 
 
 
Health Catalyst Capital Logo.png